Biotech Agency Consulting firm Experts Specialists Consultancy

For more than 30 years, Alcimed has been supporting the leaders of the biotechnology sector in their innovation and new market development projects.

Our activities for biotech players

The explorers of Alcimed’s healthcare team support everyday biotech players in a large variety of challenges in their sector: bioproduction, DTx, rare diseases, time-to-market, partnerships, artificial intelligence, market access, and more.

They trust us


Some examples of projects carried out for our clients

Our projects cover diverse subjects such as new therapeutic technologies and approaches, commercial R&D strategies, comprehension of disease treatment and care pathways, market opportunity and licensing evaluations, developing business plans and roadmaps, market access, regulatory evolution, partner search, and many more!

  • Business development strategy

    Generation gene therapy platform based on future disruptive technologies

  • Identifying partners in the field of immunology and infectious diseases

  • Assessment of antibodies for a novel oncobiologics platform

  • State of the art in biological fluid separations and the associated new business opportunities

  • Development of a standardized tool for portfolio evaluation in oncology and infectious diseases

  • Future upscaling of manufacturing capabilities of a biotech company

  • Dual branding strategy and partner evaluation for an innovative multi-indication compound

  • Novel manufacturing methods in gene therapy

Learn more about our missions and expertise

Our missions

Our expertise

What they say

  • TCV_Innovio_miniature_site_EN_min

    Mark TWYMAN

    Senior VP and Chief Commercial Officer

  • Logo_carre_Alcylam

    "We recently worked with Alcimed to support us in one of our projects. A project well carried out, with a friendly and efficient team, which respects the timings!"

    Jean-Baptiste CAQUELIN

    Marketing Director France

  • Logo_carre_Medetia

    "By bringing together multiple interests, streamlining the pace of effort for each stakeholder, and coordinating different viewpoints, Alcimed played a decisive role in the selection of the CIL'LICO consortium project, winner of the RHU (University Hospital Research Program) wave 3 competition."

    Jean-Philippe ANNEREAU

    CEO and Co-Founder

You have a project?

Embark on our adventure and join a team of 220 explorers from over 20 different nationalities with degrees from the best international universities, passionate about scientific breakthroughs, technological innovations, international development, and challenges in healthcare and climate.

Want to climb aboard?

Join our adventure

To go further